Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Community Genetics
|
June 11, 2025
The stigma of seriousness: views of genome editing scientists and policy professionals on defining serious disease
Margaret Waltz, Michael A Flatt, R Jean Cadigan
Journal of Aging Studies
|
December 4, 2009
From the Lab to the Front Line: How Individual Biogerontologists Navigate their Contested Field
Richard A Settersten, Michael A Flatt, Roselle S Ponsaran
Social Science & Medicine (1982)
|
March 22, 2015
Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine
Jennifer R Fishman, Michael A Flatt, Richard A Settersten
Sociology of Health & Illness
|
December 17, 2009
In the vanguard of biomedicine? The curious and contradictory case of anti-ageing medicine
Jennifer R Fishman, Richard A Settersten, Michael A Flatt
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
September 12, 2013
Are "anti-aging medicine" and "successful aging" two sides of the same coin? Views of anti-aging practitioners
Michael A Flatt, Richard A Settersten, Roselle Ponsaran, et al.
Journal of Community Genetics
|
February 14, 2024
Public participation in human genome editing research governance: what do scientists think?
Margaret Waltz, Michael A Flatt, Eric T Juengst, et al.
The CRISPR Journal
|
July 8, 2024
Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing
Margaret Waltz, Rebecca L Walker, Michael A Flatt, et al.
New Genetics and Society
|
April 10, 2025
Human Heritable Genome Editing and its Governance: Views of Scientists and Governance Professionals
R Jean Cadigan, Margaret Waltz, John M Conley, et al.
The Hastings Center Report
|
November 2, 2024
Preventive Human Genome Editing and Enhancement: Candidate Criteria for Governance
Eric Juengst, Michael A Flatt, John M Conley, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Community Genetics
|
June 11, 2025
The stigma of seriousness: views of genome editing scientists and policy professionals on defining serious disease
Margaret Waltz, Michael A Flatt, R Jean Cadigan
Journal of Aging Studies
|
December 4, 2009
From the Lab to the Front Line: How Individual Biogerontologists Navigate their Contested Field
Richard A Settersten, Michael A Flatt, Roselle S Ponsaran
Social Science & Medicine (1982)
|
March 22, 2015
Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine
Jennifer R Fishman, Michael A Flatt, Richard A Settersten
Sociology of Health & Illness
|
December 17, 2009
In the vanguard of biomedicine? The curious and contradictory case of anti-ageing medicine
Jennifer R Fishman, Richard A Settersten, Michael A Flatt
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
September 12, 2013
Are "anti-aging medicine" and "successful aging" two sides of the same coin? Views of anti-aging practitioners
Michael A Flatt, Richard A Settersten, Roselle Ponsaran, et al.
Journal of Community Genetics
|
February 14, 2024
Public participation in human genome editing research governance: what do scientists think?
Margaret Waltz, Michael A Flatt, Eric T Juengst, et al.
The CRISPR Journal
|
July 8, 2024
Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing
Margaret Waltz, Rebecca L Walker, Michael A Flatt, et al.
New Genetics and Society
|
April 10, 2025
Human Heritable Genome Editing and its Governance: Views of Scientists and Governance Professionals
R Jean Cadigan, Margaret Waltz, John M Conley, et al.
The Hastings Center Report
|
November 2, 2024
Preventive Human Genome Editing and Enhancement: Candidate Criteria for Governance
Eric Juengst, Michael A Flatt, John M Conley, et al.
Page
of 1